Management of Shwasa (Bronchial Asthma) with the help of Ayurved and Pranayama

Not yet recruiting

• Conditions: Other diseases of the respiratory system. Ayurveda Condition: SVASAH, (2) ICD-10 Condition: J984||Other disorders of lung. Ayurveda Condition: SVASAH, (3) ICD-10 Condition: J99||Respiratory disorders in diseasesclassified elsewhere. Ayurveda Condition: SVASAH,

• Registration Number: CTRI/2022/04/041764
• Lead Sponsor: Dr Premkumar Badwaik

Brief Summary

·         **Group A – Experimental group: -**Subjects suffering from Shwasa (Bronchial asthma) performing Nadishodhana pranayama for 10 minutes a day at 7 am on empty stomach along with standard Modern & Ayurvedic medicine (Tab. Kantakari GhanVati 500 mg BD) for 6 months – 60 patients

·         **Group B - Control group: -** Subjects suffering from Shwasa (Bronchial Asthma) performing Anuloma Viloma pranayama for 10 minutes a day at 7 am on empty stomach along with standard Modern & Ayurvedic medicine (Tab. Kantakari GhanVati 500 mg BD) for 6 months – 60 patients and we will see the relief in symptoms of Shwas (Bronchial Asthma) with follow up of one month.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2022-08-04
• Study Start: 2022-11-04

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

i)Patients suffering from mild Shwasa (Bronchial asthma) ii)Mild hypertension iii)Chronic patients of Shwasa but not on bronchodilators and steroids (Bronchial asthma) iv)Patients who are dedicated to perform pranayama as educated by yoga teacher on a regular basis.

Exclusion Criteria

i)Suffering from comorbidities ii)Congestive Cardiac failure iii)Tropical pulmonary eosinophilia iv)Old & active Pulmonary Tuberculosis v)COPD vi)Bronchiectasis vii)Spontaneous pneumothorax viii)Drug dependent cases ix)Pregnant women x)Smokers and alcoholics.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Increase in oxygen saturation (SPO2) and respiratory rate of the brochial asthma patients.	Baseline, 24 weeks

Secondary Outcome Measures

Name	Time	Method
Variation in i) PEFR (Peak flow meter)	ii) FVC, FEV1, FEV1%, PEF (Spirometry)

Trial Locations

Locations (1)

MGACH and RC Salod (H); 🇮🇳 Wardha, MAHARASHTRA, India

MGACH and RC Salod (H)

🇮🇳Wardha, MAHARASHTRA, India

Dr Premkumar Badwaik

Principal investigator

9822253328

premkumar.badwaik@dmimsu.edu.in